Clinical Trial 45743

Sarasota, FL 34243


Summary:

Help us advance RSV vaccine research in older adults.
Respiratory Syncytial Virus (RSV) is a leading cause of serious respiratory tract disease in older adults.

The Respiratory Syncytial Virus (RSV) is a highly contagious virus that impacts everyone and in mild cases presents like a common cold. However, RSV can cause more serious respiratory illness, mainly in older adults and in young infants. Similar to influenza (flu), RSV season is common during the winter months, in temperate climates. RSV and flu are different viruses. Therefore, you can still get an RSV infection even if you have been vaccinated against the flu. 

There is currently no licensed RSV vaccine, but we are now enrolling older adults in a clinical trial to evaluate an investigational RSV vaccine.


Qualified Participants Must:

• 60 years of age or older


Qualified Participants May Receive:

Study related care

May be compensentated for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.